|
ZNF28 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.507800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.189810E-01 |
| Normal-vs-Stage2 |
3.721800E-01 |
| Normal-vs-Stage3 |
8.386200E-01 |
| Normal-vs-Stage4 |
4.564600E-01 |
| Stage1-vs-Stage2 |
9.616600E-01 |
| Stage1-vs-Stage3 |
4.698200E-01 |
| Stage1-vs-Stage4 |
8.239200E-01 |
| Stage2-vs-Stage3 |
5.932400E-01 |
| Stage2-vs-Stage4 |
8.764400E-01 |
| Stage3-vs-Stage4 |
5.768000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.608000E-01 |
| Normal-vs-AfricanAmerican |
3.564200E-01 |
| Normal-vs-Asian |
1.857980E-01 |
| Caucasian-vs-AfricanAmerican |
9.538400E-01 |
| Caucasian-vs-Asian |
6.667200E-01 |
| AfricanAmerican-vs-Asian |
6.594400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.384100E-02 |
| Normal-vs-Female |
6.018000E-01 |
| Male-vs-Female |
3.703800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.458100E-02 |
| Normal-vs-Extreme_Weight |
9.962100E-03 |
| Normal-vs-Obese |
9.971400E-01 |
| Normal-vs-Extreme_Obese |
2.488800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.125000E-01 |
| Normal_Weight-vs-Obese |
1.555370E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.636000E-01 |
| Extreme_Weight-vs-Obese |
4.070200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.019400E-01 |
| Obese-vs-Extreme_Obese |
2.928600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.866000E-01 |
| Normal-vs-Age(41-60Yrs) |
9.798000E-01 |
| Normal-vs-Age(61-80Yrs) |
8.589600E-02 |
| Normal-vs-Age(81-100Yrs) |
2.138300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.523000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.136600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.603400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.454100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.131990E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.784800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.775580E-01 |
| Normal-VS-Type2 PRCC |
1.669630E-01 |
| Normal-VS-KIRP CIMP |
4.678800E-01 |
| Normal-VS-Unclassified PRCC |
3.217000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.431200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.964600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.929500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.552600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.832200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.704800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.651710E-02 |
| Normal-vs-N1 |
3.941800E-01 |
| Normal-vs-N2 |
1.418350E-03 |
| N0-vs-N1 |
1.503860E-02 |
| N0-vs-N2 |
1.816600E-01 |
| N1-vs-N2 |
5.950300E-02 |
|
|
